14. SEGMENTS (Tables)

9 Months Ended

12 Months Ended

Dec. 31, 2014

Mar. 31, 2014

Segment Reporting [Abstract]

Segment reporting

	Nine Months Ended December 31,
	2014			2013
Revenues:
Aethlon	$	563,805		$	916,796
Exosome Sciences, Inc.		–			–
Total Revenues	$	563,805		$	916,796
Operating Losses:
Aethlon	$	(2,156,769	)	$	(2,065,212	)
Exosome Sciences, Inc.		(703,411	)		(180,722	)
Total Operating Loss	$	(2,860,180	)	$	(2,245,934	)
Net Losses:
Aethlon	$	(5,347,716	)	$	(5,735,474	)
Exosome Sciences, Inc.		(703,411	)		(185,305	)
Net Loss Before Non-Controlling Interests	$	(6,051,127	)	$	(5,920,779	)
Cash:
Aethlon	$	2,446,820		$	588,066
Exosome Sciences, Inc.		328,915			1,266,875
Total Cash	$	2,775,735		$	1,854,941
Total Assets:
Aethlon	$	2,735,913		$	777,004
Exosome Sciences, Inc.		420,582			1,328,004
Total Assets	$	3,156,495		$	2,105,008
Capital Expenditures:
Aethlon	$	–		$	2,750
Exosome Sciences, Inc.		–			58,743
Capital Expenditures	$	–		$	61,493
Depreciation and Amortization:
Aethlon	$	13,328		$	7,195
Exosome Sciences, Inc.		14,686			6,964
Total Depreciation and Amortization	$	28,014		$	14,159
Interest Expense:
Aethlon	$	285,229		$	325,364
Exosome Sciences, Inc.		–			4,583
Total Interest Expense	$	285,229		$	329,947

The following tables set forth certain information regarding our segments and other operations that conforms to the consolidated balance sheet and statement of operations presented in this Report:

	Fiscal Years Ended March 31,
	2014			2013
Revenues:
Aethlon	$	1,623,769		$	1,230,004
ESI		–			–
Total Revenues	$	1,623,769		$	1,230,004
Operating Losses:
Aethlon	$	(2,651,863	)	$	(3,575,354	)
ESI		(404,065	)		–
Total Operating Loss	$	(3,055,928	)	$	(3,575,354	)
Net Losses:
Aethlon	$	(13,357,232	)	$	(4,892,040	)
ESI		(81,730	)		–
Net Loss Before Non-Controlling Interests	$	(13,438,962	)	$	(4,892,040	)
Cash:
Aethlon	$	208,259		$	125,274
ESI		1,042,020			–
Total Cash	$	1,250,279		$	125,274
Total Assets:
Aethlon	$	597,026		$	496,694
ESI		1,098,076			–
Total Assets	$	1,695,102		$	496,694
Capital Expenditures:
Aethlon	$	37,313		$	–
ESI		58,743			–
Capital Expenditures	$	96,056		$	–
Depreciation and Amortization:
Aethlon	$	11,549		$	10,484
ESI		9,538			–
Total Depreciation and Amortization	$	21,087		$	10,484
Interest Expense:
Aethlon	$	1,282,638		$	1,132,314
ESI		4,583			–
Total Interest Expense	$	1,287,221		$	1,132,314